PUBLICATION:
Breast Cancer Res Treat (2012) 133: 37. https://doi.org/10.1007/s10549-011-1683-z.

AUTHORS:
Oscar Krijgsman, Paul Roepman, Wilbert Zwart, Jason S. Carroll, Sun Tian, Femke A. de Snoo, Richard A. Bender, Rene Bernards, Annuska M. Glas

SUMMARY:
BluePrint classification of a patient cohort that was treated with neoadjuvant chemotherapy (n = 133) shows improved distribution of pathological Complete Response (pCR), among molecular subgroups compared with local pathology.

Read more: Krijgsman et al_2010_Breast Cancer Res Treat_A Diagnostic Gene Profile